Showing results (131-140 of 262) with videos related to

Sort By:
Pageof 27
Annals of Hematology|May 24, 2020
Long-term survival and polyclonal immunoglobulin reconstitution after allogeneic stem cell transplantation in multiple myelomaChristine Eisfeld, Eva Eßeling, Ramona Wullenkord, et al.
American Journal of Clinical Pathology|December 22, 2010
The stromal cell marker SPARC predicts for survival in patients with diffuse large B-cell lymphoma treated with rituximabPaul N Meyer, Kai Fu, Timothy Greiner, et al.
Cancer Research|February 18, 2011
Protein kinase C inhibitor sotrastaurin selectively inhibits the growth of CD79 mutant diffuse large B-cell lymphomasTara L Naylor, Huaping Tang, Boris A Ratsch, et al.
Chemical Communications (Cambridge, England)|May 6, 2025
Photodynamic ROS inducers delivered via electrostatic antibody targeted (ELART) nanocarriers incorporate into tumour cells and inhibit colony growthAndreas Faust, Andrew F Berdel, Evelyn Bruns, et al.
British Journal of Haematology|June 4, 2024
Early blast clearance during sequential conditioning prior to allogeneic stem cell transplantation in patients with acute myeloid leukaemiaJulian Ronnacker, Marc-Andre Urbahn, Christian Reicherts, et al.
Blood|July 9, 2004
Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study GroupGeorg Lenz, Martin Dreyling, Eva Schiegnitz, et al.
Frontiers in Oncology|November 11, 2021
Prevalence of the GFI1-36N SNP in Multiple Myeloma Patients and Its Impact on the PrognosisCyrus Khandanpour, Christine Eisfeld, Subbaiah Chary Nimmagadda, et al.
Cell Reports|October 27, 2021
Lymphocyte access to lymphoma is impaired by high endothelial venule regressionLutz Menzel, Maria Zschummel, Tadhg Crowley, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|June 2, 2020
Cyclophosphamide pulse therapy as treatment for severe interstitial lung diseasesArik Bernard Schulze, Georg Evers, Andreas Kümmel, et al.
Frontiers in Oncology|August 25, 2022
Presence of the GFI1-36N single nucleotide polymorphism enhances the response of MLL-AF9 leukemic cells to CDK4/6 inhibitionJan Vorwerk, Kaiyan Sun, Daria Frank, et al.
Pageof 27